Skip to main content
Earnings Labs
Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc. (HOWL)

NASDAQ·Healthcare·Biotechnology

$0.47

+4.99%

Mkt Cap $20.75M

Analyst Ratings

No recent rating data.

Price Target (2 analysts)

$1.00

Range $1.00$1.00

Implied Upside

+112.0%

Consensus $1.00 vs current $0.47